We would like to invite you ALL to our very exciting CELEBRATION EVENT on 17th May 2023 in BG-302.
We have been exploring disabled, chronically ill, visually impaired and neurodivergent people’s experiences of cancer services. We also explored how using the community research model can provide a level of shared understanding between researchers and community members to enable the capture of the perspectives of individuals currently underserved by health and social care research.
This project was commissioned by Macmillan Cancer Support and Wessex Cancer Alliance, and overseen by Involving People – Help & Care, Bournemouth University’s Public Involvement in Education and Research (PIER) partnership and the Research Centre for Seldom Heard Voices.
At this event, we will be sharing the outcomes of our research project, with opportunities to take a look at the report, a film which has been developed using the attendee’s artistic creations for the visuals, with the experiences they shared in a voiceover, and to engage in a creative arts workshop. A variation of healthcare professionals, academics and those with lived experience have been invited to this event, so we can all discuss the success of the project, as well as what more needs to be done.
Everyone is welcome and there will be refreshments!
Please get in touch with Stevie Corbin-Clarke (scorbinclarke@bournemouth.ac.uk) with any queries.
Community-Based Research Event – register your interest










Join the 17th Annual Postgraduate Research Conference – Wednesday 3 December 2025
BU Festival of Social Sciences invite at RNLI
MaGPIE Presents at UK Parliament: From Mass Graves to Courtroom
Festival of Social Science: Introducing drowning prevention in Bangladesh
ECR Funding Open Call: Research Culture & Community Grant – Apply Now
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Horizon Europe Work Programme 2025 Published
Horizon Europe 2025 Work Programme pre-Published
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease